Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Vogl

Showing results (281-290 of 342) with videos related to

Pageof 35
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 23, 2019
Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 TrialSergio Giralt, Luciano J Costa, David Maloney, et al.
Blood Advances|October 3, 2019
T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myelomaAlfred L Garfall, Ehren K Dancy, Adam D Cohen, et al.
Arthritis and Rheumatism|November 28, 2008
Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritisP L E M van Lent, L C Grevers, A B Blom, et al.
Leukemia|February 24, 2025
Urine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702Rahul Banerjee, Amber R Fritz, Othman S Akhtar, et al.
European Radiology|April 27, 2002
Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) -- results of a phase-III multicenter clinical trialR Sigal, T Vogl, J Casselman, et al.
Autophagy|July 4, 2014
Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myelomaDan T Vogl, Edward A Stadtmauer, Kay-See Tan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 2011
Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myelomaDan T Vogl, Tao Wang, Waleska S Pérez, et al.
Osteoarthritis and Cartilage|March 10, 2023
Intensive cholesterol-lowering treatment reduces synovial inflammation during early collagenase-induced osteoarthritis, but not pathology at end-stage disease in female dyslipidemic E3L.CETP miceY van Gemert, A B Blom, I Di Ceglie, et al.
American Journal of Hematology|August 19, 2007
Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell supportDan T Vogl, Stephen V Liu, Elise A Chong, et al.
Blood|August 24, 2023
Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapyYan Tang, Wei Liu, Siddhant Kadu, et al.
Pageof 35

Showing results (281-290 of 342) with videos related to

Sort By:
Pageof 35
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 23, 2019
Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 TrialSergio Giralt, Luciano J Costa, David Maloney, et al.
Blood Advances|October 3, 2019
T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myelomaAlfred L Garfall, Ehren K Dancy, Adam D Cohen, et al.
Arthritis and Rheumatism|November 28, 2008
Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritisP L E M van Lent, L C Grevers, A B Blom, et al.
Leukemia|February 24, 2025
Urine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702Rahul Banerjee, Amber R Fritz, Othman S Akhtar, et al.
European Radiology|April 27, 2002
Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) -- results of a phase-III multicenter clinical trialR Sigal, T Vogl, J Casselman, et al.
Autophagy|July 4, 2014
Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myelomaDan T Vogl, Edward A Stadtmauer, Kay-See Tan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 2011
Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myelomaDan T Vogl, Tao Wang, Waleska S Pérez, et al.
Osteoarthritis and Cartilage|March 10, 2023
Intensive cholesterol-lowering treatment reduces synovial inflammation during early collagenase-induced osteoarthritis, but not pathology at end-stage disease in female dyslipidemic E3L.CETP miceY van Gemert, A B Blom, I Di Ceglie, et al.
American Journal of Hematology|August 19, 2007
Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell supportDan T Vogl, Stephen V Liu, Elise A Chong, et al.
Blood|August 24, 2023
Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapyYan Tang, Wei Liu, Siddhant Kadu, et al.
Pageof 35